Cara Therapeutics
CARA
$0.68
Share price
-2.24%
Change (1 day)
-82.89%
Change (1 year)
Categories
Cara Therapeutics (CARA) - P/B ratio
P/B ratio as of April 2024 : 0.6514
According to Cara Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.6514.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cara Therapeutics - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.7091 | -80.49% |
| 2022-12-31 | 3.63 | 27% |
| 2021-12-31 | 2.86 | -5.49% |
| 2020-12-31 | 3.03 | -24.89% |
| 2019-12-31 | 4.03 | 4.78% |
| 2018-12-31 | 3.85 | -16.35% |
| 2017-12-31 | 4.60 | -7.95% |
| 2016-12-31 | 5.00 | 14.22% |
| 2015-12-31 | 4.37 | -0.59% |
| 2014-12-31 | 4.40 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 686.05% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | 147.19% | 🇺🇸 USA |
 Trevena TRVN | 2.09 | 221.28% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 0.0139 | -97.86% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 1.03 | 58.68% | 🇺🇸 USA |